Judith Kelleher-Andersson, Ph.D.
Founder, President and Chief Executive Officer (CEO)
Dr. Kelleher-Andersson has over twenty years of experience discovering and developing small-molecule, central nervous system therapeutics in the biotechnology industry. Prior to founding Neuronascent, Inc, she was Director of Drug Development and Research at Neuralstem, Inc., Centaur Pharmaceuticals and Cortex Pharmaceuticals, Inc. She strategically directed research and personnel toward indications with large unmet need. She headed the Alzheimer’s disease program in collaboration with Astra-Zeneca while at Centaur, and successfully brought a small-molecule agent to pre-nomination status (primary inventor). She invented a neurogenic depression therapeutic, while at Neuralstem, that is presently in Phase Ib. Dr. Kelleher-Andersson has over 70 US, European and World patents. She received her Ph.D. in biochemistry from University of Missouri-Columbia and completed post-graduate work at UCLA and University of California, San Francisco.